Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT06576492
Eligibility Criteria:
Main inclusion criteria:
* Male
* Subject requiring hair transplant with micrografts (strip technique or FUE technique)
* Subject aged ≥ 18 years old
* Subject having androgenetic alopecia selected by the investigator for a hair transplant
Main non-inclusion criteria:
* Subject having any other hair disorder or hair disease (telogen effluvium, alopecia areata, cicatricial alopecia, hair shaft disorder, trichotillomania…) and liable to interfere with the study assessments
* Subject having dermatological pathology or evolutive skin lesion on the scalp (psoriasis, seborrheic dermatitis, severe erythema, severe excoriation, severe sunburn, …)
* Iron deficiency (confirmation by ferritin assay results from less than 3 months performed during preoperative assessment)
* Thyroid disorders (confirmation by thyroid hormon assay results from less than 3 months performed during preoperative assessment)
* Systemic treatment with antithyroid or iron supplement established or modified within 3 months before the inclusion or planned during the study
* Radiotherapy or chemotherapy at any time before the inclusion or planned during the study
* Systemic anti-hair loss treatment (anti-androgenic treatments…) established or modified within 6 months before the inclusion visit or planned during the study
* Topical anti-hair loss treatment (Minoxidil…) established or modified within 3 months before the inclusion visit or planned during the study
* Any other systemic treatment (cardiovascular, endocrine, antidepressant, antipsychotic, …) established or modified during the previous weeks before the inclusion or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the products according to the investigator's assessment
* Any other topical treatment or product applied on the scalp within previous weeks before the inclusion or planned during the study that can limit the effectiveness of the transplant and liable to interfere with the study assessments, according to the investigator's opinion
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT06576492
Study Brief:
Protocol Section:
NCT06576492